ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $608,718 | +32.8% | 3,537 | -3.2% | 0.01% | +50.0% |
| Q2 2021 | $458,415 | -5.4% | 3,653 | +2.2% | 0.01% | -14.3% |
| Q1 2021 | $484,535 | +1.6% | 3,573 | -4.2% | 0.01% | 0.0% |
| Q4 2020 | $477,088 | +11.5% | 3,729 | -1.9% | 0.01% | 0.0% |
| Q3 2020 | $427,839 | +28.9% | 3,802 | +9.1% | 0.01% | +16.7% |
| Q2 2020 | $332,016 | -72.5% | 3,485 | -74.1% | 0.01% | -76.9% |
| Q1 2020 | $1,207,673 | +63.1% | 13,438 | -3.8% | 0.03% | +116.7% |
| Q4 2019 | $740,477 | +31.2% | 13,966 | -2.3% | 0.01% | +20.0% |
| Q3 2019 | $564,598 | -1.6% | 14,290 | +2.3% | 0.01% | 0.0% |
| Q2 2019 | $573,600 | -11.8% | 13,963 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $650,257 | +20.4% | 13,963 | +12.6% | 0.01% | +9.1% |
| Q4 2018 | $540,020 | -22.9% | 12,400 | +1.4% | 0.01% | -15.4% |
| Q3 2018 | $700,152 | -99.9% | 12,234 | 0.0% | 0.01% | +30.0% |
| Q2 2018 | $593,594,000 | +24.1% | 12,234 | 0.0% | 0.01% | +42.9% |
| Q1 2018 | $478,349,000 | +94063.2% | 12,234 | +2.2% | 0.01% | 0.0% |
| Q4 2017 | $508,000 | -69.2% | 11,968 | -72.9% | 0.01% | -30.0% |
| Q3 2017 | $1,648,000 | +145.6% | 44,164 | +100.0% | 0.01% | +100.0% |
| Q2 2017 | $671,000 | +25.4% | 22,082 | +9.2% | 0.01% | +25.0% |
| Q1 2017 | $535,000 | +3.7% | 20,217 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $516,000 | -29.5% | 20,217 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $732,000 | +6.6% | 20,217 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $687,000 | +41.6% | 20,217 | +10.1% | 0.01% | +25.0% |
| Q1 2016 | $485,000 | -36.0% | 18,367 | +18.1% | 0.00% | -33.3% |
| Q4 2015 | $758,000 | +95.9% | 15,546 | 0.0% | 0.01% | +100.0% |
| Q3 2015 | $387,000 | -22.8% | 15,546 | -1.9% | 0.00% | -25.0% |
| Q2 2015 | $501,000 | +1.4% | 15,844 | +22.0% | 0.00% | 0.0% |
| Q1 2015 | $494,000 | -2.4% | 12,985 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $506,000 | +28.8% | 12,985 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $393,000 | -10.9% | 12,985 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $441,000 | +137.1% | 12,985 | +141.3% | 0.00% | +200.0% |
| Q1 2014 | $186,000 | -44.3% | 5,382 | -36.2% | 0.00% | -50.0% |
| Q4 2013 | $334,000 | – | 8,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |